Publisher
Kluwer Academic Publishers
Reference195 articles.
1. Abo T. (2001). Extrathymic pathways of T-cell differentiation and immunomodulation. Int Immunopharmacol. 7:1261–1273.
2. Adkins B., Charyulu V., Sun Q.L. (2000). Early block in maturation is associated with thymic involution in mammary tumor-bearing mice. J Immunol. 164:5635–5640.
3. Agrawal B., Krantz M.J., Reddish M.A. et al. (1998a). Cancer-associated MUC1 mucin inhibits human T cell proliferation, which reversible by IL-2. Nature Med. 4:43–49.
4. Agrawal B., Krantz M.J., Parker J. et al. (1998b). Expression of MUC1 mucin on activated human T cells: Implication for a role of MUC1 in normal immune regulation. Cancer Res. 58:4079–4081.
5. Alleva D.G., Burger C.J., Elgert K.D. (1994). Tumor-induced regulation of suppressor macrophage nitric oxide and TNF-α production: role of tumor-derived IL-10, TGF-β and prostaglandin E2. J Immunol. 153:1674–1679.